CNST - Constellation Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
-76,075
-59,925
-35,377
-34,533
Depreciation & amortization
653
562
474
203
Deferred income taxes
-
-
-
-
Stock based compensation
5,790
3,952
1,151
848
Change in working capital
7,431
6,433
255
591
Accounts receivable
-
-
-
-
Inventory
-
-
-
-
Accounts Payable
4,003
2,751
67
423
Other working capital
-63,457
-49,299
-38,168
-33,723
Other non-cash items
158
45
326
631
Net cash provided by operating activites
-62,554
-48,823
-37,586
-32,775
Cash flows from investing activities
Investments in property, plant and equipment
-903
-476
-582
-948
Acquisitions, net
-
-
-
-
Purchases of investments
-
-
-
-
Sales/Maturities of investments
-
-
-
-
Other investing activites
-
-
-
-
Net cash used for investing activites
-43,426
-476
-582
-945
Cash flows from financing activities
Debt repayment
-1,188
-4,698
-6,634
-2,961
Common stock issued
56,033
56,031
55
60
Common stock repurchased
-
-
-
-
Dividends Paid
-
-
-
-
Other financing activites
-1,908
-3,638
-
-2,255
Net cash used privided by (used for) financing activities
72,666
147,670
17,652
19,105
Net change in cash
-33,314
98,371
-20,516
-14,615
Cash at beginning of period
88,782
16,646
37,162
51,777
Cash at end of period
55,468
115,017
16,646
37,162
Free Cash Flow
Operating Cash Flow
-62,554
-48,823
-37,586
-32,775
Capital Expenditure
-903
-476
-582
-948
Free Cash Flow
-63,457
-49,299
-38,168
-33,723